Stock Report

Nectar Lifesciences Q3 FY2022 consolidated PAT at Rs. 9.73 crores

Posted On : 2022-02-16 12:06:49( TIMEZONE : IST )

Nectar Lifesciences Limited has reported Consolidated financial results for the period ended December 31, 2021.

Financial Results (Q3 FY2022) - QoQ Comparison

The company has reported total income of Rs. 443.5309 crores during the period ended December 31, 2021 as compared to Rs. 369.668 crores during the period ended September 30, 2021.

The company has posted net profit / (loss) of Rs. 9.7314 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 1.8613 crores for the period ended September 30, 2021.

The company has reported EPS of Rs. 0.43 for the period ended December 31, 2021 as compared to Rs. 0.08 for the period ended September 30, 2021.

Financials	Q3 FY2022	Q2 FY2022	% Change
Total Income	₹ 443.5309 crs	₹369.668 crs	19.98%
Net Profit	₹9.7314 crs	₹1.8613 crs	422.83%
EPS	₹0.43	₹0.08	437.50%

Financial Results (Q3 FY2022) - YoY Comparison

The company has reported total income of Rs. 443.5309 crores during the period ended December 31, 2021 as compared to Rs.378.6533 crores during the period ended December 31, 2020.

The company has posted net profit / (loss) of Rs.9.7314 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.-8.0711 crores for the period ended December 31, 2020.

The company has reported EPS of Rs.0.43 for the period ended December 31, 2021 as compared to Rs.-0.36 for the period ended December 31, 2020.

Financials	Q3 FY2022	Q3 FY2021	% Change
Total Income	₹ 443.5309 crs	₹378.6533 crs	17.13%
Net Profit	₹9.7314 crs	₹-8.0711 crs	220.57%
EPS	₹0.43	₹-0.36	219.44%

Financial Results (9 Months Ended FY2022) - YoY Comparison

The company has reported total income of Rs.1203.3967 crores during the 9 Months period ended December 31, 2021 as compared to Rs.1197.2932 crores during the 9 Months period ended December 31, 2020.

The company has posted net profit / (loss) of Rs.13.3867 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.-32.2891 crores for the 9 Months period ended December 31, 2020.

The company has reported EPS of Rs.0.60 for the 9 Months period ended December 31, 2021 as compared to Rs.-1.44 for the 9 Months period ended December 31, 2020.

Financials	9 Months Ended FY2022	9 Months Ended FY2021	% Change
Total Income	₹1203.3967 crs	₹1197.2932 crs	0.51%
Net Profit	₹13.3867 crs	₹-32.2891 crs	141.46%
EPS	₹0.60	₹-1.44	141.67%

Shares of Nectar Lifesciences Limited was last trading in BSE at Rs. 31.25 as compared to the previous close of Rs. 30.05. The total number of shares traded during the day was 113361 in over 963 trades.

The stock hit an intraday high of Rs. 32.30 and intraday low of 30.10. The net turnover during the day was Rs. 3519594.00.